ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1366

Abdominal Adiposity and Body Composition In Rheumatoid Arthritis: Relation With Disease Characteristics In A Case-Control Study

Ivan Ferraz-Amaro1, Esmeralda Delgado-Frías2, Vanesa Hernandez-Hernandez3, Jose Ramon Muñiz4, Antonieta Gonzalez-Diaz5, Angeles Gomez Rodriguez-Bethencourt5 and Federico Diaz-Gonzalez6, 1Rheumatology, Servicio de Reumatologia. Hospital Universitario de Canarias, Tenerife, Spain, 2Rheumatology, Hospital Universitario de Canarias, La Laguna, Spain, 3Rheumatology, Rheumatology Service, Santa Cruz de Tenerife, Spain, 4Resonancia Magnética IMETISA, Resonancia Magnetica IMETISA, Santa Cruz de Tenerife, Spain, 5Servicio de Medicina Nuclear, Santa Cruz de Tenerife, Spain, 6University of La Laguna, Hospital Universitario de Canarias, La Laguna, Spain

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: body mass, cardiovascular disease and comorbidity, Disease Activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Predictors of Disease Course in Rheumatoid Arthritis - Treatment Approaches

Session Type: Abstract Submissions (ACR)

Background/Purpose: To determine the relationship between measures of body composition (total body composition derived from dual energy X-ray absorptiometry and abdominal adiposity through magnetic resonance imaging) with comorbidities in rheumatoid arthritis (RA) like disease activity, radiological damage and endothelial dysfunction. Methods: 216 subjects, 111 RA patients and 105 age and sex-matched healthy controls were included in this case-control study. Anthropometric and demographic characteristics, cardiovascular risk measurement through SCORE index, C-reactive protein (CRP), Disease Activity Score (DAS28), Health Assessment Questionnaire (HAQ), and radiological damage through Sharp index were determined. Quantification of visceral and parietal abdominal fat area was assessed using magnetic resonance imaging. Total body composition, total and regional lean mass, and fat mass and fat free mass indexes were measured by dual energy X-ray absorptiometry (DEXA). The presence of sarcopenia or overfat phenotype was established. Endothelial dysfunction was assessed through brachial artery flow-mediated dilatation sonography. Multivariate analysis was performed to define the relation of this body composition with disease characteristics. Results: 1) Body composition. Percentage of lean and fat mass did not differ between patients and controls. Appendicular to total lean mass (0.42 ± 0.02 vs. 0.40 ± 0.03, p=0.00) and appendicular to trunk lean mass (0.82 ± 0.08 vs. 0.78 ± 0.08, p=0.00) were significantly lower in RA patients. Parietal abdominal tissue was lower in male RA patients (19089 ± 1234 vs. 1345 ± 3930 cm2, p=0.02), this difference were not reached in female patients. Presence of sarcopenia tended to be higher in RA patients (13 versus 7%, p=0.17) when compared to controls. Although differences in overfat were not reached between controls and patients, 44% of RA patients had a body mass index higher than 30 kg/m2 (32% in controls, p=0.09) and 96% of RA patients were considered to be overfat through DEXA criteria (96% in controls).  2) Radiological damage. Patients with a lean mass index lower that the hypothetical percentile 25 expressed higher Sharp index when compared to patients in percentile 75 or superior (22±28 vs. 9.4±9, p=0.02) and after adjusting for disease activity. Overfat phenotypes did not show associations with radiological damage.  3) Disease activity. Sarcopenic patients had higher CRP (3.8 [1.8-29.7] vs 2.8 [1.3-7.2] mmg/dL, p= 0.04) and a trend to higher HAQ score (1.2 [0.38-1.75]  vs 0.75 [0.30-1.38], p=0.18).  4) Endothelial dysfunction. Patients with 2 standard deviation of lean mass below normality expressed lower flow-mediated when compared to controls (1.9 [0-8] vs 5.4 [0-9], p=0.14). Conclusion: Overfat and sarcopenia are present in RA patients and are related to several disease characteristics.


Disclosure:

I. Ferraz-Amaro,
None;

E. Delgado-Frías,
None;

V. Hernandez-Hernandez,
None;

J. R. Muñiz,
None;

A. Gonzalez-Diaz,
None;

A. Gomez Rodriguez-Bethencourt,
None;

F. Diaz-Gonzalez,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/abdominal-adiposity-and-body-composition-in-rheumatoid-arthritis-relation-with-disease-characteristics-in-a-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology